Sort
46,585 grants matching “heart failure”
Phosphodiesterase 1 (PDE1) Regulation of Myocardial Calcium and Function
$615,490Grace Kim Muller · Loyola University Chicago · R01 · FY2025 · HL
Identifying effective strategies used by Medicare Accountable Care Organizations to improve outcomes for patients with heart failure: A mixed-methods study
$615,489Tara C Lagu · Northwestern University At Chicago · R01 · FY2021 · HL
Gut microbiome, aging and cardiometabolic diseases in American Indians
$615,314Jinying Zhao · University Of South Florida · R01 · FY2025 · AG
CaMKII and Endothelial SK Channel Function in Diabetic Coronary Microcirculation
$615,301Jun Feng · Rhode Island Hospital · R01 · FY2025 · HL
Cardiomyocyte bromodomain protein 4 (BRD4) in physiology and disease
$615,272Joseph A. Hill · Ut Southwestern Medical Center · R01 · FY2022 · HL
Autophagy in Myocardial Ischemia/Reperfusion
$615,266Roberta A. Gottlieb · San Diego State University · P01 · FY2010 · HL
Novel Methods to Grow the Impact of Pediatric Thoracic Transplantation
$615,258Clifford Chin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HL
Structure and function of voltage-gated calcium channels
$615,256Daniel L Minor · University Of California, San Francisco · R01 · FY2017 · HL
Structure and function of voltage-gated calcium channels
$615,256Daniel L Minor · University Of California, San Francisco · R01 · FY2016 · HL
Improving Self-Care of Informal Caregivers of Adults with Heart Failure
$615,234Barbara J Riegel · University Of Pennsylvania · R01 · FY2021 · NR
Cortical Bone Stem Cell Therapy for the Infarcted Heart
$615,197Steven R Houser · Temple Univ Of The Commonwealth · R01 · FY2020 · HL
Cardiovascular health and exposure to PM2.5 constituents: a multi-cohort study
$615,182Yang Liu · Emory University · R01 · FY2020 · ES
Control of Breathing and Pompe Disease
$615,147Barry J. Byrne · University Of Florida · R01 · FY2020 · HD
Peripheral Mechanisms of Cardiopulmonary Control during Exercise
$615,120Thomas Patrick Olson · Mayo Clinic Rochester · R01 · FY2016 · HL
Novel Peptide Therapeutics for Hypertension
$615,120John C Burnett · Mayo Clinic Rochester · R01 · FY2019 · HL
Identification of a novel modulator of Pulmonary Artery Hypertension
$615,077Akiko Hata · University Of California, San Francisco · R01 · FY2019 · HL
Identification of a novel modulator of Pulmonary Artery Hypertension
$615,077Akiko Hata · University Of California, San Francisco · R01 · FY2018 · HL
Development of a Magnetically Driven Heart Pump
$615,037Barry N Gellman · Thoratec, Llc · R44 · FY2009 · HL
Pathogenicity and pathophysiology assessments of sarcomere gene variants identified in the clinic
$615,006John Travis Hinson · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · HL
Non-Coding Variants of Angiotensinogen Gene and Hypertension
$615,000Ashok Kumar Kumar · New York Medical College · R01 · FY2019 · HL
Non-Coding Variants of Angiotensinogen Gene and Hypertension
$615,000Ashok Kumar Kumar · New York Medical College · R01 · FY2017 · HL
Non-Coding Variants of Angiotensinogen Gene and Hypertension
$615,000Ashok Kumar Kumar · New York Medical College · R01 · FY2018 · HL
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
$614,993Christopher C Glembotski · University Of Arizona · R01 · FY2023 · HL
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
$614,993Christopher C Glembotski · University Of Arizona · R01 · FY2022 · HL
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
$614,993Christopher C Glembotski · University Of Arizona · R01 · FY2025 · HL